Preferred Product Characteristics (PPC) for Zika Vaccines for Endemic Use | NLM

Disaster Information Management Research Center | NLM

Preferred Product Characteristics (PPC) for Zika Vaccines for Endemic Use

08/01/2019 12:00 AM EDT

Source: World Health Organization (WHO). Published: 8/2019. In 2018 -2019, the World Health Organization, in collaboration with a working group of independent subject matter experts, developed Preferred Product Characteristics (PPC) for a Zika virus vaccine for endemic use. This nine-page document provides a table that details a vaccine characteristic, what is preferred, and product development considerations and assumptions. (PDF)